1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. BIOMOTION SCIENCES.
Biomotion Sciences.
XNAS: SLXN
Download real time
2.51 -0.08 (-3.09%)
98.88% Fall from 52W High
17,758
XNAS Volume

XNAS 21 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Biomotion Sciences. is on 23 Jul 2026 for the purpose of Silexion Therapeutics Corp Annual General Meeting for 2026 See details


Insider Trading disclosures for Biomotion Sciences.

The latest disclosure was made by Mirit Horenshtein Hadar in Biomotion Sciences. where a trade of 7,500 Ordinary Shares done was reported to US exchanges on June 4, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mirit Horenshtein Hadar CFO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2026 7,500 12,515 - 0 Ordinary Shares
Mitchell Shirvan CSO and CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2026 6,000 8,789 - 0 Ordinary Shares
Ilan Hadar Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2026 10,000 16,547 - 0 Ordinary Shares
Mitchell Shirvan CSO and CDO Sale of securities on an exchange or to another person at price $ 1.36 per share. 26 Mar 2026 22,818 27,889 - 1.4 31,032 Ordinary Shares
Ilan Hadar Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 64,350 65,471 - 0 Ordinary Shares
Shlomo Noy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 10,685 10,685 - - Stock Option (right to buy ordinary shares)
Shlomo Noy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 9,091 25,399 - 0 Ordinary Shares
Amnon Peled Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 8,904 8,904 - - Stock Option (right to buy Ordinary Shares)
Amnon Peled Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 7,576 8,237 - 0 Ordinary Shares
Mirit Horenshtein Hadar CFO and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 49,726 50,146 - 0 Ordinary Shares
Dror J. Abramov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 10,685 10,685 - - Stock Option (right to buy ordinary shares)
Dror J. Abramov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 9,091 10,180 - 0 Ordinary Shares
Avner Lushi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 10,685 10,685 - - Stock Option (right to buy ordinary shares)
Avner Lushi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 9,091 25,399 - 0 Ordinary Shares
Mitchell Shirvan CSO and CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 49,726 50,707 - 0 Ordinary Shares
Ruth Alon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 10,685 10,685 - - Stock Option (right to buy Ordinary Shares)
Ruth Alon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 9,091 10,228 - 0 Ordinary Shares
Ilan Levin Director, Ten Percent Owner 07 Aug 2025 935 372 - - Warrant (right to buy)
Ilan Levin Director, Ten Percent Owner 07 Aug 2025 450,000 456,970 - 4 1,800,000 Ordinary Shares
Ilan Levin Director, Ten Percent Owner 07 Aug 2025 5,550 6,970 - 0 Ordinary Shares
Ruth Alon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 794 794 - 0 Ordinary Shares
Amnon Peled Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 780 780 - - Stock Option (right to buy Ordinary Shares)
Amnon Peled Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 661 661 - 0 Ordinary Shares
Shlomo Noy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 1,587 1,587 - 0 Ordinary Shares
Shlomo Noy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 1,872 1,872 - - Stock Option (right to buy ordinary shares)
Dror J. Abramov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 935 935 - - Stock Option (right to buy ordinary shares)
Dror J. Abramov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 794 794 - 0 Ordinary Shares
Avner Lushi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 1,872 1,872 - - Stock Option (right to buy ordinary shares)
Avner Lushi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 1,587 1,587 - 0 Ordinary Shares
Ruth Alon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2025 935 935 - - Stock Option (right to buy ordinary shares)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters